Ultrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry.
Ultrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry.
复制标题
DOI:
10.1016/j.steroids.2015.01.014
复制
发表时间:
2015-04
期刊:
影响因子:
2.7
通讯作者:
Blair IA
中科院分区:
文献类型:
--
作者:
Wang Q;Rangiah K;Mesaros C;Snyder NW;Vachani A;Song H;Blair IA
An ultrasensitive stable isotope dilution liquid chromatography-tandem mass spectrometry method (LC-MS/MS) was developed and validated for multiplexed quantitative analysis of six unconjugated and conjugated estrogens in human serum. The quantification utilized a new derivatization procedure, which formed analytes as pre-ionized N-methyl pyridinium-3-sulfonyl (NMPS) derivatives. This method required only 0.1 mL of human serum, yet was capable of simultaneously quantifying six estrogens within 20 min. The lower limit of quantitation (LLOQ) for estradiol (E2), 16α-hydroxy (OH)-E2, 4-methoxy (MeO)-E2 and 2-MeO-E2 was 1 fg on column, and was 10 fg on column for 4-OH-E2 and 2-OH-E2. All analytes demonstrated a linear response from 0.5 to 200 pg/mL (5–2000 pg/mL for 4-OH-E2 and 2-OH-E2). Using this validated method, the estrogen levels in human serum samples from 20 female patients and 20 male patients were analyzed and compared. The levels found for unconjugated serum E2 from postmenopausal women (mean 2.7 pg/mL) were very similar to those obtained by highly sensitive gas chromatography-mass spectrometry (GC-MS) methodology. However, the level obtained in serum from older men (mean 9.5 pg/mL) was lower than has been reported previously by both GC-MS and LC-MS procedures. The total (unconjugated + conjugated) 4-MeO-E2 levels were significantly higher in female samples compared with males (p<0.05). The enhanced sensitivity offered by the present method will allow for a more specific analysis of estrogens and their metabolites. Our observations might suggest that the level of total 4-MeO-E2 could be a potential biomarker for breast cancer cases.
登录
查看更多内容
影响因子:
13.3
作者:
Blamey, R;Collins, J;Volpe, A
通讯作者:
Volpe, A
影响因子:
2
作者:
Lee, SH;Williams, MV;Blair, IA
通讯作者:
Blair, IA
DOI:
10.1016/j.jsbmb.2013.08.002
发表时间:
2013-11-01
影响因子:
4.1
作者:
Labrie, Fernand;Martel, Celine;Gomez, Jose-Luis
通讯作者:
Gomez, Jose-Luis
影响因子:
4.7
作者:
Dallal, Cher M.;Tice, Jeffrey A.;Brinton, Louise A.
通讯作者:
Brinton, Louise A.
DOI:
10.1093/jnci/djr531
发表时间:
2012-02-01
期刊:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子:
--
作者:
Fuhrman, Barbara J.;Schairer, Catherine;Ziegler, Regina G.
通讯作者:
Ziegler, Regina G.